Clinical Trials Logo

Filter by:
NCT ID: NCT06335277 Recruiting - Lymphoma Clinical Trials

Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology

Start date: February 22, 2018
Phase:
Study type: Observational

Patients eligible undergoing total body irradiation as candidates for bone marrow or peripheral stem cell transplant.

NCT ID: NCT06335251 Recruiting - Bone Metastases Clinical Trials

Radiotherapy Treatments for Neoplasms of the Limbs

Start date: February 22, 2018
Phase:
Study type: Observational

In this observational study patients treated at European Institute of Oncology with radiotherapy to limbs will be included

NCT ID: NCT06335238 Recruiting - Abdominal Cancer Clinical Trials

Radiotherapy Treatments for Neoplasms in the Abdominal-pelvic Region

Start date: February 22, 2018
Phase:
Study type: Observational

Evaluation of clinical and dosimetric aspects, tolerance, and effectiveness of abdominal-pelvic region radiotherapy treatments in patients undergoing radiotherapy for primary or secondary neoplasms localized in the tabdominal-pelvic region.

NCT ID: NCT06335173 Recruiting - Alzheimer Disease Clinical Trials

A Study to Evaluate Efficacy and Safety of Intravenous ACU193 in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

ALTITUDE-AD
Start date: February 29, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The primary purpose of this study is to evaluate the efficacy of ACU193 infusions administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's disease.

NCT ID: NCT06335030 Recruiting - Clinical trials for Autism Spectrum Disorder

Sensory and Behavioral Aspects With Particular Attention to Food Selectivity in Children With Autism

Start date: March 29, 2021
Phase:
Study type: Observational [Patient Registry]

Brief Summary: Eating problems and in particular food selectivity is a condition that worsens a long-life disorder such as Autism Spectrum Disorder (ASD) , both on an individual level, both on family and social ones . Children (2-6 years) diagnosed with ASD according to Diagnostic and Statistical Manual of Mental Disorders 5 Edition (DSM5) criteria were enrolled in an observational, cross-sectional and multicentric study conducted by three different Italian clinical centers. Regarding this sample, principal aims of the study are to describe characteristics of food selectivity, to evaluate its correlation with ASD symptoms, with cognitive and adaptive functioning of ASD preschoolers, to describe its impact on parental stress.

NCT ID: NCT06334861 Recruiting - Herpes Zoster Clinical Trials

Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine Coverage

CeVOT-Her-Zo
Start date: June 23, 2022
Phase:
Study type: Observational

The National Vaccination Program, updated by the Ministry of Health in 2021, provides a new vaccination opportunity for frail patients against Herpes zoster virus (HZ). The new treatment option, on the other hand, is designed by combining VZV-specific antigen (gE) with an adjuvant system (AS01B) to induce antigen-specific cellular and humoral immune responses in individuals with preexisting immunity to VZV. Efficacy, assessed in people given two doses 2 months apart, is around 97% in those aged 50 years and 91% in those over 70 years. In the studies conducted, HZ-related hospitalizations were significantly reduced. The vaccine schedule calls for the administration of two doses 2 months apart. The current HZ Vaccination Program implemented at the regional level recommends its active and free offer in people from 18 years of age with congenital and/or acquired immunodepression, through a collaborative relationship involving, on the one hand, multispecialist and multiprofessional medical staff and, on the other hand, citizens called to play a role that is no longer passive but the subject of empowerment by consciously making their own health choices. The collaboration with ASL Roma1, in this sense, acquires value as guarantor of the supply of the adjuvanted recombinant anti-HZ vaccine and of the appropriate reporting of vaccination coverage, which to date is still far from the targets set by the PNPV'17-'19 in adults at risk for disease. The purpose of this study Single-center prospective longitudinal observational cohort study is to verify patients' compliance with the proposed vaccination, the effectiveness of counseling carried out by a multidisciplinary team in the hospital setting.

NCT ID: NCT06334835 Recruiting - Clinical trials for Acute Lymphoblastic Leukemia, Pediatric

Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.

Start date: April 30, 2023
Phase:
Study type: Observational

Long non-coding RNAs (lncRNAs) are a class of biomarkers of crescent interest in the hematologic and oncologic field. They do not encode proteins and can alter gene expression by acting on different steps of regulation, including DNA methylation and chromatin structure. Recent data identified recurrent somatic alterations in genes involved in DNA methylation and post-translational histone modifications in T-ALL, suggesting that epigenetic homeostasis is critically required in restraining tumor development in the T-cell lineage. Further, recent studies showed that the expression levels of specific lncRNAs correlate with the prognosis of patients with Acute Lymphoblastic Leukemia of T-cells (T-ALL). The objectives of this research project are to identify T-ALL-specific lncRNAs to be used as new diagnostic and prognostic biomarkers of disease and to explore their role on chromatin reorganization and transcriptional regulation that may lead to the onset and progression of T-ALL.

NCT ID: NCT06334809 Recruiting - Prostate Cancer Clinical Trials

INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations

INSIDE
Start date: March 9, 2023
Phase:
Study type: Observational

400 patients will be enrolled and divided into 3 cohorts: Cohort A: patients with high risk localized prostate cancer (PC) defined as >cT3 or PSA > 20 ng/mL or presence of ECE or SVI at mpMRI; Cohort B: patients with de novo metastatic hormone sensitive prostate cancer (mHSPC); Cohort C: patients with metastatic castration resistant prostate cancer (mCRPC) progressing on a standard treatment.

NCT ID: NCT06334640 Recruiting - Sleep Disorder Clinical Trials

Sleeping Quality and Chronic Ocular Diseases

SONNO-OCU
Start date: October 17, 2023
Phase:
Study type: Observational

To assess the impact of sleep quality on chronic eyes diseases

NCT ID: NCT06334601 Recruiting - Clinical trials for Obstructive Sleep Apnea

Diurnal Evaluation of OSA Upper Airway Collapsibility and Muscle Responsiveness

Muscle-OSA
Start date: January 15, 2023
Phase:
Study type: Observational

In the framework of pathophysiological trait in obstructive sleep apnea (OSA) patients, a simplified method is proposed to measure upper airway (UA) collapsibility and muscle responsiveness during wakefulness.